CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

Researchers have developed a magnetic nanomaterial that can kill bone cancer cells and support bone regeneration at the same ...

From fast-food to ultra-processed snacks, a high-fat diet eaten over the long term may trigger biological changes in the ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Amgen is getting down with Disco Pharmaceuticals, commissioning the German biotech to work on cancer therapies focused on a ...

Genotoxic drugs, the focus of this new study, are commonly used to treat bowel cancer by killing cancer cells through damage ...

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of small cell lung cancer. Small cell lung cancer (SCLC) is among the most ...

Collaboration with Amgen to advance a cancer target discovered using DISCO’s proprietary surfaceome mapping technology Cologne, Germany, January 7, 2026 – DISCO Pharmaceuticals (“DISCO”), today ...

Immune cells are most commonly engineered to kill cancers, but now, scientists have shown the technique makes the gut lining of older mice resemble that of younger mice, raising hopes that the same ap ...

The fungal compound verticillin A, discovered more than 50 years ago, has long been regarded for its potential ...